
Escitalopram
Escitalopram is a widely used SSRI. A network meta-analysis of 522 trials found all antidepressants beat placebo for depression, with escitalopram among the more effective and better tolerated in head-to-head trials, and a second network meta-analysis found it effective for generalized anxiety disorder. St. John's wort is the critical supplement interaction; cannabis products are a high-severity concern and saffron a low one.
Prescription medication: not a dietary supplement
This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.
Quick decision guide
May help most
Adults and teens with major depression, or adults and children 7 and older with generalized anxiety disorder, whose prescriber recommends an SSRI
Common dosing range
Set by your prescriber. The Lexapro label recommends 10 mg once daily, with a maximum of 20 mg once daily; 10 mg is the recommended dose for most older adults and people with liver problems
When to expect effects
The trials that established it lasted 8 weeks; in one anxiety trial, improvement over placebo was measurable from week 1
Watch out for
Boxed warning for suicidal thoughts and behaviors in children, teens and young adults. Never combine with MAO inhibitors or pimozide. Raises serotonin syndrome risk with St. John's wort and other serotonergic products, and bleeding risk with blood thinners and NSAIDs. Do not stop suddenly: the label recommends a gradual reduction set by your prescriber
What is it
Escitalopram is a prescription antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. It is sold as generic escitalopram tablets and under the brand name Lexapro. The Lexapro label approves it for major depressive disorder in adults and children 12 years and older, and for generalized anxiety disorder in adults and children 7 years and older. It is the S-isomer, the active half, of the older antidepressant citalopram.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
major depressive disorder Good Evidence | Modest; response odds about 1.4 to 2.1 times placebo across antidepressants | Adults with moderate to severe major depression | Measured over acute treatment trials, typically about 8 weeks |
generalized anxiety disorder Good Evidence | Modest; about 2.5 points more improvement on the Hamilton Anxiety Scale than placebo | Adult outpatients with generalized anxiety disorder | Improvement over placebo from week 1 in one trial; trials lasted 8 weeks |
preventing relapse after response Good Evidence | Large in anxiety (19% vs 56% relapse) and moderate in depression (26% vs 40%) | Adults who have already responded well to escitalopram | Measured over 36 weeks (depression) and 24 to 76 weeks (anxiety) |
major depressive disorder
- Effect
- Modest; response odds about 1.4 to 2.1 times placebo across antidepressants
- Best fit
- Adults with moderate to severe major depression
- Time
- Measured over acute treatment trials, typically about 8 weeks
generalized anxiety disorder
- Effect
- Modest; about 2.5 points more improvement on the Hamilton Anxiety Scale than placebo
- Best fit
- Adult outpatients with generalized anxiety disorder
- Time
- Improvement over placebo from week 1 in one trial; trials lasted 8 weeks
preventing relapse after response
- Effect
- Large in anxiety (19% vs 56% relapse) and moderate in depression (26% vs 40%)
- Best fit
- Adults who have already responded well to escitalopram
- Time
- Measured over 36 weeks (depression) and 24 to 76 weeks (anxiety)
Evidence for 3 uses
AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.
major depressive disorder
Disease adjunctA 2018 network meta-analysis of 522 double-blind trials with 116,477 adults found that all 21 antidepressants studied were more effective than placebo for acute treatment of major depression, with odds ratios from 1.37 to 2.13. In head-to-head trials, escitalopram was among the more effective drugs and also among the better tolerated, with fewer dropouts than many others. The authors rated the certainty of evidence moderate to very low overall. The review left out trials in which 20% or more of participants had bipolar, psychotic or treatment-resistant depression.
Bottom line: Escitalopram works better than placebo for depression and is one of the better tolerated options.
generalized anxiety disorder
Disease adjunctA 2019 network meta-analysis of 89 randomized trials with 25,441 adult outpatients found escitalopram more effective than placebo for generalized anxiety disorder, lowering the Hamilton Anxiety Scale score by 2.45 points more (95% credible interval 1.63 to 3.27), with relatively good acceptability. In one 8-week trial of 315 adults, 58% responded on escitalopram 10 to 20 mg a day compared with 38% on placebo, and improvement was measurable from week 1.
Bottom line: Escitalopram is one of several drugs that reliably ease generalized anxiety, by a modest margin.
preventing relapse after response
Disease adjunctTwo randomized trials tested staying on escitalopram after it had worked. In 274 adults whose depression responded, relapse over 36 weeks was 26% on continued escitalopram versus 40% on placebo (hazard ratio 0.56). In 375 adults whose generalized anxiety responded to 20 mg a day, 19% relapsed on continued escitalopram versus 56% on placebo over 24 to 76 weeks. Both trials enrolled only people who had already responded to escitalopram.
Bottom line: For people it helps, continuing escitalopram lowers the chance of the illness coming back.
How it works
How to take it
What to track
Bottom line: Your prescriber sets the dose; take it once a day, with or without food, and never stop suddenly on your own.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Suicidal thoughts and behaviors (boxed warning). Antidepressants increased these in children, teens and young adults in short-term studies; anyone taking escitalopram should be watched for worsening mood, especially in the first months and after dose changes. Lexapro is not approved for children younger than 7.
Serotonin syndrome, a potentially life-threatening reaction, especially with other serotonergic products (triptans, tricyclic antidepressants, opioids such as tramadol and fentanyl, lithium, tryptophan, buspirone, amphetamines, St. John's wort) or MAO inhibitors.
Higher risk of bleeding, from bruising and nosebleeds to life-threatening hemorrhage, greater with aspirin, NSAIDs, warfarin and other blood thinners.
Discontinuation symptoms after stopping, particularly when abrupt, such as dizziness, irritability, anxiety, headache and electric-shock sensations; the label recommends a gradual reduction.
Low blood sodium (hyponatremia), more likely in older adults and people taking diuretics; signs include headache, confusion, weakness and unsteadiness.
Seizures, activation of mania or hypomania in people with bipolar disorder (the label advises screening before starting), and angle-closure glaucoma in people with untreated narrow eye angles.
Who should avoid it
- People taking an MAO inhibitor or within 14 days of stopping one, and people being treated with linezolid or intravenous methylene blue; at least 14 days must also pass after stopping escitalopram before starting an MAOI
- People taking pimozide (contraindicated)
- People with known hypersensitivity to escitalopram, citalopram or any inactive ingredient
- Children younger than 12 with depression or younger than 7 with anxiety: the label says safety and effectiveness have not been established in them
Pregnancy & breastfeeding
Pregnancy: the Lexapro label says published studies and postmarketing reports have not established an increased risk of major birth defects or miscarriage. SSRI use, particularly in the month before delivery, has been linked to a less than 2-fold higher risk of heavy bleeding after birth, and use later in pregnancy may increase the risk of persistent pulmonary hypertension in the newborn and of breathing, feeding or temperature problems after birth. Untreated depression also carries risks, and women who stop antidepressants are more likely to relapse. Breastfeeding: escitalopram and its metabolite pass into breast milk (in a study of 8 mothers, infants received about 3.9% of the maternal weight-adjusted dose), and there are reports of excess sedation, restlessness, poor feeding and poor weight gain in exposed infants; the label says to weigh the benefits of breastfeeding against the mother's need for treatment and to monitor the infant.
Interactions
The Lexapro label lists St. John's wort among serotonergic products that raise the risk of serotonin syndrome, a potentially life-threatening reaction, with escitalopram. A systematic review of St. John's wort interactions also identified possible serotonergic interactions with SSRIs; it can also speed up drug-clearing liver enzymes, including CYP3A4, which the Lexapro label names as one of the main enzymes that clear escitalopram, though these sources do not report its effect on escitalopram levels. Do not combine them without your prescriber's advice, and if you already take both, contact your prescriber rather than stopping anything on your own.
The Lexapro label says combining escitalopram with tryptophan, the amino acid the body turns into serotonin, increases the risk of serotonin syndrome, a potentially life-threatening reaction, and its highlights say the combination is not recommended. No case with this exact pair has been published. Do not add a tryptophan supplement unless your prescriber advises it, and seek emergency care for agitation, tremor, fever, fast heartbeat, heavy sweating or muscle stiffness.
5-HTP is the body's direct building block for serotonin, so it adds to escitalopram's serotonin effect. The Lexapro label names tryptophan, the amino acid the body turns into 5-HTP, among products that increase the risk of serotonin syndrome; it does not name 5-HTP itself, and no escitalopram case has been published. Do not combine them unless your prescriber directs it, and seek emergency care for agitation, tremor, fever, fast heartbeat, heavy sweating or muscle stiffness.
Contraindicated because of the risk of serotonin syndrome. The label requires at least 14 days between stopping an MAOI and starting escitalopram, and at least 14 days after stopping escitalopram before starting an MAOI.
Contraindicated. Racemic citalopram raised levels of pimozide, a drug with a narrow safety margin, which may increase the risk of QT prolongation and dangerous heart rhythms.
Cannabidiol (CBD) blocked the enzymes that break down citalopram and escitalopram in lab tests, and in 6 patients taking citalopram or escitalopram, adding CBD raised their drug levels; in 20 healthy adults, CBD raised citalopram exposure by about 43%. A case report describes repeated serotonin syndrome in a man taking fluoxetine (another antidepressant) after high-THC cannabis oil or a THC vape, and cites similar recent cases in people taking antidepressants. Tell your prescriber about any cannabis or CBD use, and seek urgent care for agitation, tremor, sweating, fever or a fast heartbeat.
Escitalopram increases bleeding risk, and the label says aspirin, NSAIDs, other antiplatelet drugs, warfarin and other anticoagulants may add to it. People on warfarin need careful INR monitoring. Ask your pharmacist before using an over-the-counter pain reliever.
In a clinical trial, escitalopram did not increase alcohol's effects on thinking and coordination, but the Lexapro label still recommends against alcohol, and its Medication Guide says not to drink during treatment. Both can affect alertness, so do not drive after drinking. One case of serotonin syndrome after a can of beer involved escitalopram plus a second antidepressant, clomipramine; a single case is a signal, not proof. Be honest with your prescriber about drinking, and do not stop escitalopram on your own.
Saffron may act partly on serotonin, which raises a theoretical concern about added effects with escitalopram. In an 8-week trial of 160 adults already taking an antidepressant, adding a standardized saffron extract improved clinician-rated depression scores and did not worsen antidepressant side effects; the trial did not report results for escitalopram users separately. Discuss it with your prescriber before using a saffron supplement.
Documented interactions
Evidence-graded pair pages with sources, dosing notes, and timing guidance, a complement to the narrative section above.
Warnings (4)
+ 5-htp
criticalEscitalopram is a selective serotonin reuptake inhibitor (SSRI) that keeps serotonin active longer, and 5-HTP (5-hydroxytryptophan) is the direct building block the body turns into serotonin, so taking both can push serotonin activity too high and cause serotonin syndrome, a potentially life-threatening reaction. The Lexapro label names tryptophan, the amino acid the body turns into 5-HTP, among serotonergic drugs that increase this risk; it does not name 5-HTP itself. No case with escitalopram and 5-HTP was found; the concern rests on the label, the shared mechanism and a published case of serotonin syndrome when 5-HTP was taken with sertraline, another SSRI.
+ st. john's wort
criticalEscitalopram is an SSRI cleared mainly by CYP2C19 and CYP3A4. St. John's wort independently raises serotonin and speeds up those same enzymes in people. Taken together, the combination can trigger serotonin syndrome, a potentially life-threatening reaction, and the escitalopram label lists St. John's Wort among the drugs that raise this risk. St. John's wort could also lower escitalopram levels, but no study has measured this. Published serotonin syndrome cases involve other antidepressants rather than escitalopram specifically.
+ tryptophan
criticalEscitalopram is a selective serotonin reuptake inhibitor (SSRI) that keeps serotonin active longer, and L-tryptophan is the amino acid the body turns into serotonin, so taking both can push serotonin activity too high. The Lexapro label says combining escitalopram with other serotonergic drugs, naming tryptophan in the same list as St. John's wort, increases the risk of serotonin syndrome, a potentially life-threatening reaction. Its highlights say use with tryptophan is not recommended. No published case with this exact pair was found; the rating follows the label warning and matches the rating for tryptophan with sertraline, fluoxetine and venlafaxine.
+ alcohol
moderateThe Lexapro label says escitalopram did not increase alcohol's effects on thinking and coordination in a clinical trial, but it still recommends against alcohol, and the Medication Guide says not to drink during treatment. Escitalopram can itself cause sleepiness or slow thinking and reactions, and alcohol adds its own impairment. One published case described serotonin syndrome after a can of beer in a man taking escitalopram with a second antidepressant, clomipramine; a single case is a signal, not proof.
Choosing a product
What to look for on the label, and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
Can I take St. John's wort with escitalopram?⌄
This page rates it a critical interaction. The Lexapro label lists St. John's wort among products that raise the risk of serotonin syndrome with escitalopram. Talk to your prescriber before using it, and if you have been combining them, contact your prescriber rather than stopping anything on your own.
Is CBD or cannabis safe with escitalopram?⌄
This page rates it high severity. CBD raised citalopram and escitalopram levels in small studies, and high-potency THC cannabis has been linked to serotonin syndrome in people on other antidepressants. Tell your prescriber about any cannabis or CBD use so they can watch for side effects.
Can I drink alcohol while taking escitalopram?⌄
In a study, escitalopram did not worsen the effects of alcohol on thinking and coordination, but the label still says alcohol is not recommended during treatment. Alcohol can also make depression and anxiety harder to treat, so be open with your prescriber about how much you drink.
Is saffron safe with escitalopram?⌄
The concern is theoretical. In a trial of adults already on antidepressants, adding saffron did not worsen side effects, but results for escitalopram were not reported separately. This page rates it low severity. Ask your prescriber before starting a saffron supplement.
What happens if I stop escitalopram suddenly?⌄
Stopping suddenly can cause discontinuation symptoms such as dizziness, irritability, anxiety, headache and electric-shock sensations. The label recommends a gradual reduction rather than stopping abruptly. Talk to your prescriber before making any change.
References by claim
major depressive disorder
Cipriani et al., 2018 · PMC (2018) link
generalized anxiety disorder
preventing relapse after response
Safety
Lexapro (escitalopram) tablets prescribing information · DailyMed (FDA label) link
Interaction: St. John's wort
Henderson et al., 2002 · PMC (2002) link
Interaction: 5-HTP (5-hydroxytryptophan)
Patel et al., 2017 · PMC (2017) link
Interaction: Cannabis and CBD products
Interaction: Alcohol
Suzuki et al., 2019 · PubMed (2019) link
Interaction: Saffron (supplements)
Lopresti et al., 2019 · PubMed (2019) link
Track Escitalopram with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora app.
Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.
